Supplier
CSL BEHRING
Mechelen · BEL
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Awards
5
Total awarded
€97.3m
2 joint award(s) counted pro rata
Buyers
5
Sectors
1
Group: CSL Behring GmbH
Reg. 0454483701_81002f42-fba9-4e17-ac9b-286059973ac0
Contracts this supplier holds that are running out
- €10,469,900
24 Sept 2027
estimated - €16,277,080
22 Oct 2027
estimated 2 Nov 2027
estimatedPolyvalente hooggeconcentreerde immunoglobulinen (humaan plasma) voor intraveneuze toediening€128,334,002Hospilim VZWCSL BEHRING, DEPARTEMENT CENTRAL DE FRACTIONNEMENT, Prothya Biosolutions Netherlands B.V. +1 more
- €19,300,000
30 Sept 2028
stated - €27,331,500
31 Dec 2030
stated
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Polyvalente hooggeconcentreerde immunoglobulinen (humaan plasma) voor intraveneuze toediening | Hospilim VZW | CSL BEHRING, DEPARTEMENT CENTRAL DE FRACTIONNEMENT, Prothya Biosolutions Netherlands B.V. +1 more | €128,334,002 | 3 Nov 2026 |
| PHARM-2026-845 - 1 | Cliniques universitaires Saint Luc | CSL BEHRING, TAKEDA BELGIUM | €16,277,080 | 21 Oct 2026 |
| Raamovereenkomst voor het leveren van immunoglobulines IV 10% | Universitair Ziekenhuis Gent | CSL BEHRING | €27,331,500 | 22 Sept 2026 |
| IV Immunoglobulinen (90% deel) | VZW Maria Middelares | CSL BEHRING | €19,300,000 | 22 Sept 2026 |
| Intraveneuze immunoglobulinen 100mg/ml | Algemeen Ziekenhuis Sint-Maria vzw | CSL BEHRING | €10,469,900 | 11 Sept 2026 |